Alisertib
| CAS No. | 1028486-01-2 |
|---|---|
| MDL No. | MFCD16621243 |
| MF | C27H20ClFN4O4 |
| MW | 518.90 |
| InChI Key | ZLHFILGSQDJULK-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Alisertib is an organic heterotricyclic compound with a 5H-pyrimido[5,4-d][2]benzazepine core substituted at positions 2, 7, and 9 by chloro, (4-carboxy-3-methoxyphenyl)amino, and 2-fluoro-6-methoxyphenyl groups, respectively. It is an aurora A kinase inhibitor (IC50 ~1 nM) and functions as an antineoplastic agent, apoptosis inducer, and autophagy inducer. It is classified as an organochlorine compound, a monomethoxybenzene, a member of monofluorobenzenes, a methoxybenzoic acid, and a secondary amino compound.
| CAS No. | 1028486-01-2 |
|---|---|
| Product Name | Alisertib |
Biological Targets
AURKA
Associated Conditions
multiple myeloma·cancer·breast cancer·non-small cell lung carcinoma·urinary bladder cancer·
* The information provided here is compiled from public sources and is for reference only.
